Drug intelligence / Profile preview

ipomoea obscura extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Topical, Intraperitoneal
01

Overview

Ipomoea obscura extract is a botanical extract derived from the aerial parts (primarily leaves and stems) of Ipomoea obscura, a perennial climbing herb widely distributed in India and Southeast Asia. Traditionally used in Ayurveda and Siddha medicine, it is recognized for its application in treating conditions such as diarrhoea, ulcers, wounds, inflammatory disorders, and for its analgesic and immunomodulatory effects[4][1][6]. Scientific studies demonstrate a broad range of pharmacological activities including anti-inflammatory, antioxidant, antibacterial, antifungal, anti-angiogenic, anti-tumor, nephroprotective, and immunomodulatory properties[3][4][5]. Mechanistically, its anti-inflammatory and immunomodulatory effects are attributed to the inhibition of key pro-inflammatory cytokines (such as TNF-α, IL-1β, IL-6, GM-CSF), inhibition of inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) modulation[3][4]. The extract also downregulates VEGF and matrix metalloproteinase (MMP) production, leading to anti-angiogenic effects[4]. Its antioxidant effect is linked to an enrichment in phenolic compounds and flavonoids, especially quercetin and kaempferol, with additional presence of lupeol and β-sitosterol[5]. The plant is not a synthetic pharmaceutical product but is commonly curated as a dietary supplement or as part of botanical therapeutics in complementary medicine.

Other names
laksmana extractvelvet morning glory extract
02

Targets

Mpro (3C-like proteinase of SARS-CoV-2)CA9 (Carbonic anhydrase IX)ACE2 (Angiotensin-converting enzyme 2)

Beyond the preview

Go deeper on ipomoea obscura extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ipomoea obscura extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call